comprehensive -WSS

comprehensive

author：fashion 2025-09-30 01:12:15 - browse：58624

Adobe

The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan, which led to the health insurance company in California losing hundreds of millions of dollars in bonuses from the government, a judge ruled Monday.

The decision will lead to more than $250 million funneling back into SCAN, which covers 270,000 Medicare Advantage enrollees. And it opens the door for other Medicare Advantage plans to potentially recoup huge sums of taxpayer-funded bonuses — even though many independent experts believe the quality rating system is flawed and doesn’t appropriately gauge quality of care for older adults and people with disabilities.

The Centers for Medicare and Medicaid Services, the federal agency that oversees all Medicare programs, said it does not comment on litigation. In an interview, SCAN CEO Sachin Jain told STAT that if the company had not gotten its expected bonus money, it would have had to shave benefits and reduce what it pays hospitals and doctors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Lawmakers consider Medicare pay reforms for doctors

explore

knowledge

WSS

Departing Stanford president retracts two papers

Eli Lilly expects to double planned employment in Boston center

Diversity in medical illustrations gets boost from Chidiebere Ibe

Why health workers in Gaza are injured or die at high rates

Neuroscience startup Neumora files for IPO

What do new weight loss drugs mean for bariatric surgery?

knowledge

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

knowledge

What does generative AI mean for health care? We asked experts

UnitedHealth’s board chair also owns a personal investment firm

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Eli Lilly expects to double planned employment in Boston center

Medicare proposal to cover medical devices draws a mixed reaction

In science, is the line between industry and academia shifting?

Malaria cases in Florida and Texas: Here’s what you need to know

Pharmacists can make shortage drugs, but at what cost?

Virginia high school admissions case could be legal follow

Will Ozempic

knowledge

Senate committee scrutinizes Medicare Advantage brokers

How to make AI work for medicine

CEOs share strategies for surviving biotech slump

Eli Lilly expects to double planned employment in Boston center

CEOs share strategies for surviving biotech slump

In science, is the line between industry and academia shifting?

explore

hotspot

knowledge

hotspot